CAT
76
2
ETN
67
4
DAL
74
-2
AMP
69
3
DTE
42
2
CCI
36
2
ADM
48
-3
CMS
58
-2
D
43
-2
CCL
55
-2
CHRW
76
-3
AAP
36
-5
BBY
41
-9
CRM
57
7
A
48
-3
DVA
47
-3
AN
63
2
EL
52
-10
CF
48
3
BAX
42
-5
CAT
76
2
ETN
67
4
DAL
74
-2
AMP
69
3
DTE
42
2
CCI
36
2
ADM
48
-3
CMS
58
-2
D
43
-2
CCL
55
-2
CHRW
76
-3
AAP
36
-5
BBY
41
-9
CRM
57
7
A
48
-3
DVA
47
-3
AN
63
2
EL
52
-10
CF
48
3
BAX
42
-5
Financhill
Back

State Street SPDR S&P Biotech ETF Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
75

XBI
State Street SPDR S&P Biotech ETF

Last Price:
$123.29
Seasonality Move:
4.35%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

State Street SPDR S&P Biotech ETF Stock Forecast

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 13.1% based on the past 19 years of stock performance.
  • State Street SPDR S&P Biotech ETF has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
  • Is State Street SPDR S&P Biotech ETF Stock Undervalued?
    The current State Street SPDR S&P Biotech ETF [XBI] share price is $123.25. The Score for XBI is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • XBI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will State Street SPDR S&P Biotech ETF Stock Go Up Next Year?

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 13.1% based on the past 19 years of stock performance.

State Street SPDR S&P Biotech ETF Stock Rating

Buy
75
State Street SPDR S&P Biotech ETF (XBI) is a Buy

Is State Street SPDR S&P Biotech ETF overpriced?

  • State Street SPDR S&P Biotech ETF has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%

State Street SPDR S&P Biotech ETF Stock Price History

Is XBI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
123.47
52-Week Low:
66.66

Prediction Charts

Market Cap:
0
Price in USD:
123.25
Volume:
11M
Beta:
0.96

Technical Analysis

SMA50:
110.28
SMA100:
100.15
SMA200:
91.36
52-Wk Change:
24.76%

Stock Predictions

  • Is State Street SPDR S&P Biotech ETF stock public?
    Yes, State Street SPDR S&P Biotech ETF is a publicly traded company.
  • What is the State Street SPDR S&P Biotech ETF stock quote today?
    The State Street SPDR S&P Biotech ETF stock price is 123.25 USD today.
  • How to buy State Street SPDR S&P Biotech ETF stock online?
    You can buy State Street SPDR S&P Biotech ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 111.18 114.01 115.36 111.11
Nov-17 113.51 114.83 116.18 113.06
Nov-18 113.93 115.18 115.90 113.25
Nov-19 114.81 114.50 115.52 113.47
Nov-20 116.15 113.83 117.90 113.74
Nov-21 113.82 116.65 117.63 113.57
Nov-24 117.21 119.58 119.79 117.11
Nov-25 119.84 121.37 121.41 119.56
Nov-26 121.55 122.85 123.47 120.96
Nov-28 123.03 123.16 123.28 122.49
Dec-1 121.85 119.85 121.97 119.74
Dec-2 119.80 118.46 120.26 117.72
Dec-3 118.76 121.83 121.96 118.74
Dec-4 121.22 123.25 123.61 120.78

State Street SPDR S&P Biotech ETF Earnings

Data Unavailable

State Street SPDR S&P Biotech ETF Forecast Revenue Growth

Data Unavailable

* State Street SPDR S&P Biotech ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.